Skip to main content
editorial
. 2019 Sep 18;5(3):138–144. doi: 10.1016/S2055-6640(20)30043-1

Figure 1.

Figure 1.

Difference in SVR12 rate between black and non-black subjects for those with HCV GT1 alone and those with both HCV GT1 and HIV for 12-week regimens. CI: confidence interval; GT1: genotype 1; HCV: hepatitis C virus; SVR12: sustained virological response assessed 12 weeks following cessation of treatment; TE: treatment experienced; TN: treatment naive